Overview of Chronic GVHD Response Assessment
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
ASTCT offers its members the information, tools and forms they need to stay informed and involved in efforts to develop more effective treatments for chronic graft-versus-host disease (chronic GVHD) an urgent unmet clinical need and the most frequent complication after HCT. This presentation is by Steven Z. Pavletic, M.D., National Cancer Institute, NIH, after the 2014 Consesn Conference on GVHD.
Key:
Complete
Next
Failed
Available
Locked
Overview of Chronic GVHD Response Assessment
Open to download resource.
Open to download resource.
ASTCT offers its members the information, tools and forms they need to stay informed and involved in efforts to develop more effective treatments for chronic graft-versus-host disease (chronic GVHD) — an urgent unmet clinical need and the most frequent complication after HCT. This presentation is by Steven Z. Pavletic, M.D., National Cancer Institute, NIH, after the 2014 Consensus Conference on GVHD.
